Table 1.: Main Clinical and Spirometric Characteristics of 134 Children (Mean Age 10.95; 98 Males and 36 Females) Enrolled in the Study

  Under Control (n=98) Not Under Control (n=36) All Patients n=134
Negative Bronchodilation Test (n=81) Positive Bronchodilation Test (n=17)
Asthma severity Intermittent 34 (42%) 7 (41 %) 7 (19%) 48 (36%)
41 (42%)
Mild persistent 40 (50%) 7 (40%) 19 (53%) 66 (49%)
47 (48%)
Moderate persistent 7 (9%) 3 (18%) 7 (19%) 17 (13%)
10 (10%)
Severe persistent 0 0 3 (8%) 3 (2%)
0
Controller medications ICS* 50 (51%) 8 (47%) 17 (47%) 67 (50%)
42 (52%)
ICS*+ LABA 11 (11%) 2 (12%) 6 (17%) 17 (13%)
9 (11%)
Only reliever medications 37 (38%) 7 (41%) 13 (36%) 50 (37%)
30 (37%)

*ICS: inhaled corticosteroids; LABA: long-acting β2agonists; bronchodilation test was considered to be positive when deltaFEV1≥ 12%; deltaFEV1= (FEV1postBD-FEV1at baseline) / FEV1 at baseline.